Carlos Cordon-Cardo, MD, PhD
img_Carlos Cordon-Cardo
PROFESSOR AND SYSTEM CHAIR | Pathology, Molecular and Cell Based Medicine
PROFESSOR | Genetics and Genomic Sciences
PROFESSOR | Oncological Sciences
Research Topics
Cancer, Cancer Genetics, Cell Biology, Genomics, Molecular Biology, Pathology, Prostate, Proteomics, Stem Cells
Multi-Disciplinary Training Area
Cancer Biology [CAB], Genetics and Genomic Sciences [GGS]

PhD, Cornell University Medical College

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Cordon-Cardo during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Board Service

  • Queen Sofia Spanish Institute

Consulting or Other Professional Services: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Champalimaud Foundation

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • PreciseDx

Founder/Co-Founder/Partner:

  • PreciseDx

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.